Wells Fargo has recently downgraded its investment rating for cell therapy company ARCELLX, INC. from "Overweight" to "Equal Weight".
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
However, the institution has simultaneously raised the target stock price from $100 to $115, demonstrating recognition of the company's long-term value. This rating adjustment reflects the analysts' balanced consideration between short-term risks and long-term potential. The upward revision of the target price may be based on ARCELLX's technological advancements in the CAR-T cell therapy field or positive signals from clinical trial data.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Sources: US-Canada Tariff Negotiations Stalemated
Cointime•2026/08/15 08:31
XRP sentiment weakens, but on-chain activity reaches highest levels in months
币界网•2026/08/15 07:53

Expert Analyst Examines What the Big Whales Are Doing in Bitcoin Right Now
BitcoinSistemi•2026/08/15 07:31
BUILDon targets its 20-day EMA as short liquidations outpace longs
AMBCrypto•2026/08/15 07:03

Crypto prices
MoreBitcoin
BTC
$62,857.5
+0.05%
Ethereum
ETH
$1,874.7
+0.02%
Tether USDt
USDT
$0.9990
-0.01%
USDC
USDC
$0.9999
-0.00%
XRP
XRP
$1
-0.48%
Solana
SOL
$74.99
-0.96%
TRON
TRX
$0.3320
-0.39%
Hyperliquid
HYPE
$55.99
-1.15%
Dogecoin
DOGE
$0.06985
+0.02%
Zcash
ZEC
$487.9
-0.28%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now